These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
61 related items for PubMed ID: 10200465
1. Sensitivity of S49.1 cells to anti-CD95 (Fas/Apo-1)-induced apoptosis: effects of CD95, Bcl-2 or Bcl-x transduction. Broome HE, Dargan CM, Brunner T, Green DR. Cell Death Differ; 1998 Mar; 5(3):200-5. PubMed ID: 10200465 [Abstract] [Full Text] [Related]
2. Dexamethasone induces apoptosis in human T cell clones expressing low levels of Bcl-2. Gilardini Montani MS, Tuosto L, Giliberti R, Stefanini L, Cundari E, Piccolella E. Cell Death Differ; 1999 Jan; 6(1):79-86. PubMed ID: 10200551 [Abstract] [Full Text] [Related]
3. Fas (APO-1/CD95)-mediated apoptosis is independent of bcl-2: a study with cell lines overexpressing bcl-2 and with bcl-2 transfected cell lines. Gazitt Y, Hu WX. Int J Oncol; 1998 Jan; 12(1):211-20. PubMed ID: 9454907 [Abstract] [Full Text] [Related]
4. A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells. Friesen C, Kiess Y, Debatin KM. Cell Death Differ; 2004 Jul; 11 Suppl 1():S73-85. PubMed ID: 15105835 [Abstract] [Full Text] [Related]
6. NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins. Todaro M, Zerilli M, Triolo G, Iovino F, Patti M, Accardo-Palumbo A, di Gaudio F, Turco MC, Petrella A, de Maria R, Stassi G. Arthritis Rheum; 2005 Jul 15; 52(7):2179-91. PubMed ID: 15986355 [Abstract] [Full Text] [Related]
7. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Fulda S, Meyer E, Debatin KM. Cancer Res; 2000 Jul 15; 60(14):3947-56. PubMed ID: 10919673 [Abstract] [Full Text] [Related]
8. Regulation of apoptosis in mature alphabeta+CD4-CD8- antigen-specific suppressor T cell clones. Khan Q, Penninger JM, Yang L, Marra LE, Kozieradzki I, Zhang L. J Immunol; 1999 May 15; 162(10):5860-7. PubMed ID: 10229821 [Abstract] [Full Text] [Related]
9. In vitro generated human memory-like T cells are CD95 type II cells and resistant towards CD95-mediated apoptosis. Fas SC, Baumann S, Krueger A, Frey CR, Schulze-Bergkamen H, Brenner D, Stumpf C, Kappes K, Krammer PH. Eur J Immunol; 2006 Nov 15; 36(11):2894-903. PubMed ID: 17048269 [Abstract] [Full Text] [Related]
10. Retroviral transduction of human peripheral blood lymphocytes with Bcl-X(L) promotes in vitro lymphocyte survival in pro-apoptotic conditions. Eaton D, Gilham DE, O'Neill A, Hawkins RE. Gene Ther; 2002 Apr 15; 9(8):527-35. PubMed ID: 11948378 [Abstract] [Full Text] [Related]
11. Follicular dendritic cells protect malignant B cells from apoptosis induced by anti-Fas and antineoplastic agents. Schwarz YX, Yang My, Qin D, Wu J, Jarvis WD, Grant S, Burton GF, Szakal AK, Tew JG. J Immunol; 1999 Dec 15; 163(12):6442-7. PubMed ID: 10586034 [Abstract] [Full Text] [Related]
12. Effects of differential overexpression of Bcl-2 on apoptosis, proliferation, and telomerase activity in Jurkat T cells. Johnson VL, Cooper IR, Jenkins JR, Chow SC. Exp Cell Res; 1999 Aug 25; 251(1):175-84. PubMed ID: 10438583 [Abstract] [Full Text] [Related]
13. CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. Smith KG, Strasser A, Vaux DL. EMBO J; 1996 Oct 01; 15(19):5167-76. PubMed ID: 8895561 [Abstract] [Full Text] [Related]
14. Apoptotic behaviour of hepatic and extra-hepatic tumor cell lines differs after Fas stimulation. Lamboley C, Bringuier AF, Feldmann G. Cell Mol Biol (Noisy-le-grand); 2000 Feb 01; 46(1):13-28. PubMed ID: 10726968 [Abstract] [Full Text] [Related]
15. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2. Dirsch VM, Stuppner H, Vollmar AM. Cancer Res; 2001 Aug 01; 61(15):5817-23. PubMed ID: 11479221 [Abstract] [Full Text] [Related]
16. Conversion of Fas-resistant to Fas-sensitive MCF-7 breast cancer cells by the synergistic interaction of interferon-gamma and all-trans retinoic acid. Danforth DN, Zhu Y. Breast Cancer Res Treat; 2005 Nov 01; 94(1):81-91. PubMed ID: 16136269 [Abstract] [Full Text] [Related]
17. T cell apoptosis causes peripheral T cell depletion in mice transgenic for the HIV-1 vpr gene. Yasuda J, Miyao T, Kamata M, Aida Y, Iwakura Y. Virology; 2001 Jul 05; 285(2):181-92. PubMed ID: 11437653 [Abstract] [Full Text] [Related]
18. Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment. Kobayashi T, Ruan S, Jabbur JR, Consoli U, Clodi K, Shiku H, Owen-Schaub LB, Andreeff M, Reed JC, Zhang W. Cell Death Differ; 1998 Jul 05; 5(7):584-91. PubMed ID: 10200513 [Abstract] [Full Text] [Related]
19. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway. Ashany D, Savir A, Bhardwaj N, Elkon KB. J Immunol; 1999 Nov 15; 163(10):5303-11. PubMed ID: 10553053 [Abstract] [Full Text] [Related]
20. Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis. Hinz S, Trauzold A, Boenicke L, Sandberg C, Beckmann S, Bayer E, Walczak H, Kalthoff H, Ungefroren H. Oncogene; 2000 Nov 16; 19(48):5477-86. PubMed ID: 11114725 [Abstract] [Full Text] [Related] Page: [Next] [New Search]